None
HU
Bumper Month of Clinical Trial News to Ring Out This Vax Series
['Hilda Bastian', '.Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow', 'Class', 'Wp-Block-Co-Authors-Plus', 'Display Inline', 'Sourceurl Https', 'Absolutelymaybe.Plos.Org Wp-Content Plugins Co-Authors-Plus Build Blocks Block-Coauthors Style-Index.Css', '.Wp-Block-Co-Authors-Plus-Avatar', 'Where Img', 'Height Auto Max-Width']
Absolutely Maybe
Before I get to the bumper crop of recent clinical trial news, there is news about this monthly update.
There are reports of clinical trial results for 2 mucosal vaccines, another intranasal vaccine has gone into a phase 1 trial, and 4 clinical trials for nextgen Covid vaccines have reached full recruitment or completion.
Back to contentsNew clinical trial resultsPhase 1 trial results for the intranasal OMV vaccine from Intravacc (Netherlands)This vaccine is OMV-based.
Another intranasal Covid vaccine going into clinical trialThe 37th mucosal Covid vaccine to reach the clinical trial phase is an intranasal live attenuated vaccine from RocketVax (Switzerland).
Previous update posts specifically on next generation Covid vaccines prior to this monthly series (beginning May 2023):All my posts on Covid vaccines, beginning from March 2020, are tagged here.